Proton pump inhibitors and the risk of severe COVID-19: a post-hoc analysis from the Korean nationwide cohort

Gut. 2021 Oct;70(10):2013-2015. doi: 10.1136/gutjnl-2020-323672. Epub 2020 Dec 10.
No abstract available

Keywords: COVID-19; proton pump inhibition.

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • Cohort Studies
  • Humans
  • Proton Pump Inhibitors* / adverse effects
  • Republic of Korea / epidemiology
  • SARS-CoV-2

Substances

  • Proton Pump Inhibitors